Tens Of Thousands Of People In West Africa Are Expected To Begin Receiving Experimental Ebola Vaccines From January, But Mass Immunization Is Still Far Off, According To The World Health Organization. Clinical Trials Of The Glaxo-Smith-Kline And New-Link Genetics Vaccines Are Under Way, With 500 Volunteers Due To Take Part In Countries Including The United States, Britain, Germany, Switzerland, Mali, Gabon And Kenya.